Terms: = Colorectal cancer AND PR, PGR, progesterone receptor
1154 results:
1. Multilevel analysis of social determinants of advanced stage colorectal cancer diagnosis.
Dantas AAG; de Oliveira NPD; Costa GAB; Martins LFL; Dos Santos JEM; Migowski A; de Camargo Cancela M; de Souza DLB
Sci Rep; 2024 Apr; 14(1):9667. PubMed ID: 38671078
[TBL] [Abstract] [Full Text] [Related]
2. Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors.
Frentzas S; Austria Mislang AR; Lemech C; Nagrial A; Underhill C; Wang W; Wang ZM; Li B; Xia Y; Coward JIG
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38642937
[TBL] [Abstract] [Full Text] [Related]
3. Exploring treatment outcomes in Stage II-III rectal cancer patients undergoing neoadjuvant therapy at a tertiary care center in Pakistan: a comprehensive analysis of pathological outcomes.
Soomro MY; Khan SR; Muhammad H; Ahmad S; Zehra N; Ali I; Samar MR; Hameed A; Moosajee M; Rashid YA
BMC Cancer; 2024 Apr; 24(1):479. PubMed ID: 38627736
[TBL] [Abstract] [Full Text] [Related]
4. The HLA-I landscape confers prognosis and antitumor immunity in breast cancer.
Ding XH; Xiao Y; Chen F; Liu CL; Fu T; Shao ZM; Jiang YZ
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38602320
[TBL] [Abstract] [Full Text] [Related]
5. Intratumor tertiary lymphatic structure evaluation predicts the prognosis and immunotherapy response of patients with colorectal cancer.
Feng H; Zhang S; Zhou Q; Han F; Du G; Wang L; Yang X; Zhang X; Yu W; Wei F; Hao X; Ren X; Zhao H
Front Immunol; 2024; 15():1302903. PubMed ID: 38500886
[TBL] [Abstract] [Full Text] [Related]
6. Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors.
Corcoran RB; Do KT; Kim JE; Cleary JM; Parikh AR; Yeku OO; Xiong N; Weekes CD; Veneris J; Ahronian LG; Mauri G; Tian J; Norden BL; Michel AG; Van Seventer EE; Siravegna G; Camphausen K; Chi G; Fetter IJ; Brugge JS; Chen H; Takebe N; Penson RT; Juric D; Flaherty KT; Sullivan RJ; Clark JW; Heist RS; Matulonis UA; Liu JF; Shapiro GI
Clin Cancer Res; 2024 May; 30(9):1739-1749. PubMed ID: 38456660
[TBL] [Abstract] [Full Text] [Related]
7. Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China.
Yan H; Song L; Li Y; Xu Q; Guo W; Lin S; Jiang W; Wang Z; Deng L; Huang Z; Qin H; Zhang X; Tong F; Zhang R; Liu Z; Zhang L; Yu J; Dong X; Gong Q; Deng J; Chen X; Wang J; Zhang G; Yang N; Zhang Y; Zeng L
Cancer Immunol Immunother; 2024 Mar; 73(4):74. PubMed ID: 38451314
[TBL] [Abstract] [Full Text] [Related]
8. Value of diffusion kurtosis MR imaging and conventional diffusion weighed imaging for evaluating response to first-line chemotherapy in unresectable pancreatic cancer.
Zhang Z; Zhang Y; Hu F; Xie T; Liu W; Xiang H; Li X; Chen L; Zhou Z
Cancer Imaging; 2024 Feb; 24(1):29. PubMed ID: 38409049
[TBL] [Abstract] [Full Text] [Related]
9. Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.
Coleman N; Stephen B; Fu S; Karp D; Subbiah V; Ahnert JR; Piha-Paul SA; Wright J; Fessahaye SN; Ouyang F; Yilmaz B; Meric-Bernstam F; Naing A
Cancer Med; 2024 Feb; 13(3):e6877. PubMed ID: 38400671
[TBL] [Abstract] [Full Text] [Related]
10. Radiological complete response with regorafenib for multiple lung metastases of ascending colon cancer: a case report.
Kikuchi K; Ogawa M; Sasaki A
J Med Case Rep; 2024 Feb; 18(1):45. PubMed ID: 38321556
[TBL] [Abstract] [Full Text] [Related]
11. Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report.
Zhang T; Huang X; Liu W; Ling X; Su Z; Huang M; Che S
Diagn Pathol; 2024 Jan; 19(1):25. PubMed ID: 38297350
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of phenomic profiles in the All of Us Research Program against the US general population and the UK Biobank.
Zeng C; Schlueter DJ; Tran TC; Babbar A; Cassini T; Bastarache LA; Denny JC
J Am Med Inform Assoc; 2024 Apr; 31(4):846-854. PubMed ID: 38263490
[TBL] [Abstract] [Full Text] [Related]
13. The enigma of incisional hernia prediction unraveled: external validation of a prognostic model in colorectal cancer patients.
Amro C; Smith L; Shulkin J; McGraw JR; Hill N; Broach RB; Torkington J; Fischer JP
Hernia; 2024 Apr; 28(2):547-553. PubMed ID: 38227093
[TBL] [Abstract] [Full Text] [Related]
14. Efficacy, safety and genomic analysis of SCT200, an anti-EGFR monoclonal antibody, in patients with fluorouracil, irinotecan and oxaliplatin refractory RAS and BRAF wild-type metastatic colorectal cancer: a phase Ⅱ study.
Yang L; Zhang W; Fan N; Cao P; Cheng Y; Zhu L; Luo S; Zong H; Bai Y; Zhou J; Deng Y; Ba Y; Liu T; Aili M; Yin X; Gu K; Dai G; Ying J; Shi J; Gao Y; Li W; Yu G; Xie L; Gai W; Wang Y; Meng P; Shi Y
EBioMedicine; 2024 Feb; 100():104966. PubMed ID: 38217945
[TBL] [Abstract] [Full Text] [Related]
15. Validity assessment of the POLARS score tool in the prediction of post rectal cancer surgery LARS score in a population-based Swedish cohort.
Rethy B; Nordenvall C; Pieniowski E; Jansson-Palmer G; Johar A; Lagergren P; Abraham-Nordling M
BMJ Open Gastroenterol; 2024 Jan; 11(1):. PubMed ID: 38199776
[TBL] [Abstract] [Full Text] [Related]
16. Case report: hepatic arterial infusion chemotherapy combined with sintilimab and lenvatinib for conversion therapy of colorectal cancer liver metastases.
Peng K; Li Y; Su H; Lan C; Huang Z; Wei Y; Liao X; Peng M; Peng T; Zhu G
Front Immunol; 2023; 14():1325445. PubMed ID: 38173715
[TBL] [Abstract] [Full Text] [Related]
17. A pyroptosis-related signature in colorectal cancer: exploring its prognostic value and immunological characteristics.
Jiang P; Fan J; Huang S; Liu L; Bai M; Sun Q; Shen J; Zhang N; Liu D; Zhou N; Feng Y; Jiang J; Zhu J
PeerJ; 2023; 11():e16631. PubMed ID: 38144182
[TBL] [Abstract] [Full Text] [Related]
18. Pneumorrhachis Secondary to a Locally Advanced Rectal cancer with Pre-Sacral Abscess-Case Report and Review.
Diaconescu R; Popovici D; Tarta C; Isaic A; Costachescu D; Totolici B
Medicina (Kaunas); 2023 Nov; 59(12):. PubMed ID: 38138179
[TBL] [Abstract] [Full Text] [Related]
19. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
[TBL] [Abstract] [Full Text] [Related]
20. Application of the 'online assessment + FOBT at home' to improve participation and the efficacy of opportunistic screening for colorectal cancer: a retrospective cohort study.
Peng X; Tang G; Wang Y; Zeng F; Chen Y; Zhang W; Mo C; Yang Y; Li S; Bai L; Xiao D; Zheng G; Ran W; Chen C; Yang Y; Gao Y; Zhu S; Huang Z; Zhao D; Wu C; Xu L; Wei Z
BMC Public Health; 2023 Dec; 23(1):2534. PubMed ID: 38110887
[TBL] [Abstract] [Full Text] [Related]
[Next]
